Main Menu

Professor Emma Hall

Team Leader

The alt text
Professor Emma Hall is a medical statistician with a particular interest in clinical trials that aim to maximise the treatment of urological, and head and neck cancers. She is the Deputy Director of the Cancer Research UK-funded Clinical Trials and Statistics Unit. Team: ICR-CTSU Urology and Head and Neck trials

T 020 8722 4292


Professor Emma Hall is a Reader of Oncology Trials and Deputy Director of the Cancer Research UK-funded Clinical Trials and Statistics Unit at The Institute of Cancer Research (ICR-CTSU). She is a chartered statistician with over 20 years’ experience in the design, methodology and analysis of oncology clinical trials.

She is a member of two Clinical Studies Groups at the National Clinical Research Institute (NCRI): for Prostate and Bladder & Renal cancers. Professor Hall also co-chairs one of the four Workstreams at the NCRI's Clinical and Translational Radiotherapy Research Group (CTRad) that focuses on 'Phase 3 Trials and Methodology' and is a member of CTRad’s Executive Committee.

Professor Hall sits on the independent data monitoring and trial steering committees for a number of international and national clinical trials and is a member of the Marie Curie Research Funding Committee. She leads the ICR-CTSU’s portfolio of research in urological and head and neck cancers.

Her current research interests includes the design and analysis of radiotherapy trials, novel agent/biomarker studies in metastatic castrate resistance prostate cancer and trials evaluating the treatment and management of bladder and rarer genitourinary cancers.

We use cookies to ensure that we give you the best experience on our website. By continuing to use this website, you are agreeing to our use of cookies on your device as described in our cookie policy. You can change your cookie settings at any time but parts of our site will not function correctly without them.